In The News
The Need for Speed
New evidence from Dr. Goldsmith’s lab suggests that individuals with schizophrenia or schizoaffective disorder have slower outcomes on psychomotor tasks. Read more at Psychiatric Times.
New evidence from Dr. Goldsmith’s lab suggests that individuals with schizophrenia or schizoaffective disorder have slower outcomes on psychomotor tasks. Read more at Psychiatric Times.
A new paper from our group examines the combined presence of high blood glucose and low tyrosine metabolism in people with Major Depressive Disorder.
Several institutions and organizations including our own are advancing the research of anti-inflammatory drugs as treatment methods for depression and depressive symptoms. Read about it at Nature.
Neuroinflammation is rapidly being tied to a number of physical and cognitive health issues, presenting a new direction for potential treatments.
Dr. Miller spoke with Dave Asprey on his Podcast, Bulletproof radio, to discuss inflammation’s effects on aging. Listen to it here.
How can you maintain your motivation during stressful times? Our research provides one answer. See more at Inc.
Christopher Bergland takes a look at our research on inflammation and motivation at Psychology Today.
Computational modeling provides a new look at chronic, low grade inflammation’s effects on motivation. Read more at Medical Express.
Inflammation research at Emory helps develop our understanding of treatment-resistant depression. Dr. Miller discusses this research with Healio.
Dr. Sarah Gingell analyzes an unexpected question with the help of our recent findings. Read about it in Psychology Today.